Results 341 to 350 of about 869,856 (392)
Base editing enables precise nucleotide substitutions but limited by bystander editing. This study engineers plant base editors by fusing optimized TadA variants with PAM‐flexible SpRY nickase, enabling A‐to‐G, C‐to‐T, and dual‐base conversions in a highly condensed window (≤3 nucleotides). Additionally, TadDBE (TadA Dual‐Base Editor)‐mediated directed
Kangli Sun+14 more
wiley +1 more source
Adenosine transmission from hypothalamic tanycytes to AGRP/NPY neurons regulates energy homeostasis. [PDF]
Kim N, Kim S, Park S, Kim EK.
europepmc +1 more source
EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer
Drug‐tolerant persister (DTP) cells emerge early during EGFR‐TKI treatment, preceding the development of acquired resistance. Elevated DPP4 in DTP cells drives metabolic reprogramming and antioxidant adaptation, promoting cell survival under drug pressure.
Yuanzhou Zhang+7 more
wiley +1 more source
Synthesis of Nucleoside Derivatives by Biomimetic Ester Migration. [PDF]
Kurrle NJ+8 more
europepmc +1 more source
This study demonstrates a pump‐free, hydraulic‐amplification oscillatory microfluidic device, which generates oscillatory flows by deforming flexible microchannels through reciprocating finger pressing. The mechanism of elasto‐inertial focusing in the oscillatory flows is revealed, and early detection of drug‐treated platelet aggregates and rapid cell ...
Yong Liu+3 more
wiley +1 more source
Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway. [PDF]
Wang S, Pan X, Liang R, Chen S.
europepmc +1 more source
EXERCISE EFFECTS ON MUSCLE GLUCOSE UPTAKE AND INSULIN ACTION [PDF]
Derave, Wim
core +1 more source
AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists
De novo GLP‐1RAs can be computationally designed to exhibit extended half‐life and superior efficacy compared to Semaglutide. Abstract Peptide drugs have revolutionized modern therapeutics, offering novel treatment avenues for various diseases. Nevertheless, low design efficacy, time consumption, and high cost still hinder peptide drug design and ...
Ting Wei+13 more
wiley +1 more source
Neuropharmacology adenosine A<sub>2A</sub> receptor and glial glutamate transporter GLT-1 are synergistic targets to reduce brain hyperexcitability after traumatic brain injury in mice. [PDF]
Alves M+5 more
europepmc +1 more source